About MICH-PhD

<<     PROCEEDING by SCITE-PRESS was PUBLISHED. it can be DOWNLOADED from Header Menu

One of the challenges in drug development is through genomic approaches. The presence of genetic variation in human can cause different drug responses, so that it need personalized medicine. The lack of personalized medicine in chronic disease treatment is one of the challenges for further research development. In addition, the drug designs or structure modification and also the development of natural product can be applied for prevention or as a treatment intervention in chronic diseases. Furthermore, to increase patient adherence to their medication, the pharmaceutical formulation especially the drug dosage form development, is needed. Beside that, pharmacoeconomics play role to evaluate the effectiveness of patient treatment costs. The discovery of bioactive compounds can support the handling of chronic diseases, and by using Health Technology Assessment (HTA) will obtain safety and cost effective medicines.

Faculty of Pharmacy and Science of Universitas Muhammadiyah Prof. DR. HAMKA (UHAMKA) in collaboration with Association of Muhammadiyah Pharmacy Higher Education (APTFM) in Indonesia would organize the first International Conference entitled “Muhammadiyah International Conference on Health and Pharmaceutical Development (MICH-PhD)" with the theme of “Current Innovation in Chronic Disease Treatment”. It aims to provide an opportunity for participants to present their researches and to expose participants to the development and innovation made in health and various disciplines of pharmacy.
At the conference, participants will have a meeting place to expand their knowledge of current development in pharmacogenetics, pharmacoeconomics, targetting therapy, etc. This event will be a good opportunity for them to share their research findings and to establish networks. Providing a precious opportunity, MICH-PhD invites student, academicians, pharmaceutical scientists and other researchers, pharmaceutical organizations, and all representatives of pharmacy to showcase their cutting edge findings and at the same time to be exposed to useful collections of research and the latest developments. This event is expected to give significant contributions to the society, particularly in medical and pharmaceutical developments.

Keynote Speaker


Prof. Dr. dr. Nila Djuwita F. Moeloek, Sp.M.*

        Minister of Health of the Republic of Indonesia

Plenary Speakers

Card image cap
dr. Rizki Edmi Edison, PhD

Director of Neuroscience Centre
Universitas Muhammadiyah Prof. Dr. HAMKA, Indonesia
Expertise: Neuroscience
View Profile

Card image cap
Dr. Arthorn Riewpaiboon

Social and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy
Mahidol University, Thailand
Health Economics, Pharmacoeconomics, Hospital Cost Analysis, Cost of Illness Analysis and Economic Evaluation
View Profile

Card image cap
Prof. Dr. B. (Bob) Wilffert

Department of PharmacoTherapy, PharmacoEpidemiology and PharmacoEconomics
University of Groningen, The Netherlands
Pharmacotherapy, Pharmacogenetics, Clinical Pharmacology, Drug and Pregnancy
View Profile

Card image cap
Dr. Nining Sugihartini, M.Si., Apt.

Vice Dean of Faculty of Pharmacy
Universitas Ahmad Dahlan
Pharmaceutical Sciences
View Profile

Prof. Patrick Ball

School of Pharmacy, Faculty of Science and Engineering
University of Wolverhampton,United Kingdom
Pharmacy, Clinical Pharmacy, Medication Adherence and Medication in life stage
View Profile

Dr. Hana Morrissey

Senior Lecturer of School of Pharmacy, Faculty of Science and Engineering
University of Wolverhampton,United Kingdom
Pharmacy, Chronic Disease Management, Clinical Pharmacy, Medication Adherence, Primary Care, Therapeutic and Community Pharmacy
View Profile

Call for Paper

Authors are requested to submit abstract to the Organizing Committee by April 7th, 2018 May 8th, 2018 June 27th, 2018 EXTENDED.  The abstract is maximum 200 words and should follow the template which consists of introduction & aims, the method used, result, and conclusion. Accepted abstracts will be required to submit a manuscript of 3000 words. The papers should be written in English, must be between 4 to 6 pages should follow the templateAll papers will undergo a double-blind peer review process by experts according to their fields. All accepted paper will be processed to publish on Scopus indexed proceeding*) or Pharmaciana (DOAJ indexed and Accredited -DIKTI- journal). Other papers not included on both choices above will be directed to Google Scholar indexed Journal.

*) on confirmation

Please prepare your full paper at once so that it can be uploaded immediately when the abstract announcement is released

The scope of Paper in the conference include but not limited to :

  • Pharmacology
  • Toxicology
  • Immunology
  • Histology
  • Molecular biology
  • Natural products
  • Microbiology
  • Biochemistry
  • Molecular docking
  • Medicinal chemistry
  • Clinical research
  • Pharmacoeconomics
  • Pharmacovigilance 
  • Drug design
  • Drug delivery vehicle
  • Pharma-nanotechnology
  • Biopharmaceuticals
  • Drug formulation

Important Dates

Abstract Submission
January 2nd - April 7th, 2018  ➨ May 8th, 2018   ➨ June 27th, 2018   ➨ >>July 22th, 2018<<     FINAL EXTENDED
Announcement of Abstract AcceptanceApril 16th, 2018  ➨ May 18th, 2018   ➨ June 29th, 2018   ➨ >>July 22th, 2018<<     FINAL EXTENDED
Full Paper SubmissionMay 2nd - May 16th, 2018  ➨ June 30th, 2018   ➨ >>July 22th, 2018<<     FINAL EXTENDED
Early Bird Registration and Payment
January 2nd - April 30th, 2018
Regular Registration and Payment
May 2nd - August 4th, 2018
Conference DaysAugust 10th - 11th, 2018


Best Western Premier The Hive


Organized by 
Supported by APTFM members

Faculty of Pharmacy and Science

Universitas Muhammadiyah Prof. DR. HAMKA